Arktus Therapeutics Co., Ltd.

Arktus Therapeutics Co., Ltd.

Private
KyotoHealthcare & Life Scienceshttps://arktustx.com/

Last Round

Series A

Sep 22, 2025

Total Funding Raised

$7.32M

Company Overview

Arktus Therapeutics Co., Ltd. is a biotechnology company that develops regenerative medicine for knee cartilage repair using iPS cell and 3D-printing technologies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, 3D Printing, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales, Government Contracts

AI Layer

Non-AI

Keywords

regenerative medicinecartilage regenerationknee osteoarthritisiPS cells3D bioprintingcartilage implanttissue engineeringcell therapystem cell therapyinduced pluripotent stem cellsscaffold-free implantmesenchymal stem cellsMSCspre-clinical stageprecision medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Arktus Therapeutics Co., Ltd. Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Arktus Therapeutics Co., Ltd. Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series ASep 22, 2025
SeedApr 10, 2024

Arktus Therapeutics Co., Ltd. Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 22, 2025

    Raised $4.46M from multiple venture capital firms.

  • Apr 10, 2024

    $2.86M round led by Kyoto University Innovation Capital

Arktus Therapeutics Co., Ltd. Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Arktus Therapeutics Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Arktus Therapeutics Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersKyoto
Year Founded2023
Last FundingSep 22, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.